PCBL Chemical Q2 FY26 – The Carbon King, The Chemical Prince, and the ₹5,000-Cr Debt Elephant Nobody Wants to Talk About
1. At a Glance – Carbon, Chemistry & Confusion in One ₹13,600-Cr Package
What happens when India’s largest carbon black producer suddenly decides it wants to become a chemical conglomerate, a green energy player, and a battery-materials innovator — all while carrying ₹5,252 crore debt? You get PCBL Chemical Ltd, a company that’s literally turning soot into sustainability.
In Q2 FY26, the stock shut shop at ₹362 — down 25 % YoY and -14 % in six months. Investors are watching like parents at a science fair: proud, but terrified the experiment might explode.
Quarterly revenue came in at ₹2,164 crore (flat YoY), while PAT halved to ₹61.5 crore (-50 %). The company still flexes a 14.3 % OPM, but profit margins are melting faster than polar ice. Meanwhile, management announced a 600 % interim dividend — because nothing screams confidence like paying cash while your leverage ratio looks like a 12-year-old’s math error.
Market-cap ₹13,664 crore, P/E 39×, ROE 12.5 %. Industry P/E 36.8×. Debt ₹5,252 crore. This is what accountants call “respectable madness.”
2. Introduction – From Tyre Dust to Tech Dreams
If Reliance built an empire from polyester, PCBL’s trying to do it from soot. Born in 1960 as Phillips Carbon Black, the company spent decades supplying the tyre industry with a magic black powder that makes rubber stronger and accountants happier.
But sometime in 2023, someone at RP-Sanjiv Goenka Group had a mid-life crisis and said, “Why stop at tyres when we can make water-treatment chemicals, phosphonates, and EV battery materials too?” And thus, PCBL became PCBL Chemical Ltd — new name, same chaos.
Today, it claims to be:
India’s largest carbon-black maker,
World’s 7th largest overall,
Top 3 global in phosphonates post-Aquapharm acquisition, and
A wannabe in battery chemicals with its Nanovace venture.
The only thing larger than its ambition is its debt figure. But hey, this is the RP-Sanjiv Goenka Group — they eat leverage for breakfast and belch dividends by dinner.
3. Business Model – WTF Do They Even Do?
Imagine a company that sells three products no one can pronounce but every factory needs.
Carbon Black (678 KT Rubber + 112 KT Specialty): The OG business. Used in tyres, conveyor belts, hoses, shoe soles — basically everything that rolls, grips, or squeaks. PCBL sells it under brands like Orient Black and CarboNext.
Specialty Chemicals (Phosphonates & Performance Blacks): This is the glow-up after the ₹3,800 crore acquisition of Aquapharm Chemicals in 2024. Suddenly, PCBL found itself selling water-treatment and oil-field chemicals to Europe and the US — a serious side hustle.
Battery & Nano Materials: Through subsidiary Nanovace Technologies, PCBL is building nano-silicon and acetylene-black plants for EV batteries. Pilot plant under construction in Gujarat; US patent secured. Because why not? Even soot wants to go electric now.
Plus, every carbon-black unit produces waste gas — which PCBL converts into 134 MW of green power. That’s right, they literally burn fumes for electricity. ESG investors call it sustainability; engineers call it jugaad.
4. Financials Overview – Where the Chemistry Gets Messy
Source table
Metric
Latest Qtr (Q2 FY26)
YoY Qtr (Q2 FY25)
Prev Qtr (Q1 FY26)
YoY %
QoQ %
Revenue (₹ Cr)
2,164
2,163
2,114
0 %
+2.4 %
EBITDA (₹ Cr)
266
364
319
-27 %
-16.6 %
PAT (₹ Cr)
61.5
123
94
-50.1 %
-34.5 %
EPS (₹)
1.63
3.27
2.49
-50.1 %
-34.5 %
Commentary: Half the profit evaporated, and the CFO still had to announce a ₹6 per-share interim dividend. Bold move, Cotton. Margins compressed under acquisition costs and higher interest — ₹107 crore of interest in Q2 alone. That’s nearly two entire Aquapharm factories worth of EMI.
EV = ₹ 18,627 Cr EBITDA TTM ≈ ₹ 1,200 Cr → EV/EBITDA = 15× Peers average 13–17×, fair EV range = ₹ 15,600 – ₹ 19,800 Cr Minus Net Debt ₹ 5,200 Cr → Equity Value ₹ 10,400 – ₹ 14,600 Cr ÷ 37.8 Cr shares → ₹ 275 – ₹ 385 per share
Method 3 – DCF (Detective Edition)
FCF growth 7 % CAGR, terminal 4 %, discount 11 %.
10-year horizon → ₹ 300 – ₹ 360 per share
✅ Fair Value Range (Educational): ₹ 250 – ₹ 380 CMP ₹ 362 sits near the upper band — the market already priced the Aquapharm dream but not yet the debt hangover. Disclaimer: Educational analysis only.
6. What’s Cooking – News, Triggers, & Corporate Masala
